Within-clinic reagent strip lipid measurement

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Biomedical Instrumentation

Background:

• Dry chemistry analyzers offer point-of-care testing advantages.
• Accurate lipid measurements are crucial for diagnosing and managing hyperlipidemia.

Purpose of the Study:

• To assess the agreement between the Reflotron dry chemistry analyzer and standard laboratory methods for total cholesterol and triglycerides.
• To evaluate between-method variability and its clinical implications.

Main Methods:

• Paired comparison of replicate measurements from venous blood samples.
• Analysis of 105 cholesterol and 90 triglyceride specimens.
• Assessment of mean differences, limits of agreement, and repeatability coefficients.

Main Results:

• No significant mean difference for cholesterol, but wide limits of agreement (-0.87 to 0.90 mmol/L) indicate potential clinical discrepancies.
• Poor repeatability for both methods limited agreement.
• Significant systematic difference for triglycerides, with Reflotron reading lower (0.30 mmol/L less) than laboratory methods, and limits of agreement of -0.09 to 0.70 mmol/L.

Conclusions:

• The Reflotron analyzer exhibits clinically significant variability for cholesterol and triglyceride measurements compared to laboratory methods.
• Clinicians should be aware of these agreement limits when using the Reflotron for hyperlipidemia screening or monitoring diabetic patients.
• Poor repeatability in both analytical systems contributes to the observed discrepancies.